Literature DB >> 22706536

Retrospective study of the utility of FLIPI/FLIPI-2 for follicular lymphoma patients treated with R-CHOP.

Ayumi Numata, Naoto Tomita, Katsumichi Fujimaki, Masatsugu Tanaka, Chizuko Hashimoto, Rika Oshima, Kenji Matsumoto, Shiro Matsuura, Wataru Yamamoto, Shigeki Motomura, Yoshiaki Ishigatsubo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22706536     DOI： 10.3960/jslrt.52.77

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN： 1346-4280


× No keyword cloud information.
  4 in total

1.  Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies.

Authors:  Niklas Gebauer; Britta Mengler; Svenja Kopelke; Alex Frydrychowicz; Alexander Fürschke; Carsten Hackenbroch; Arthur Bauer; Armin Riecke; Nikolaus von Bubnoff; Sebastian Fetscher; Hanno M Witte
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-20       Impact factor: 4.322

2.  Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.

Authors:  Chi Hoon Maeng; Sung Woo Ahn; Seong-Yoon Ryu; Sungjun Han; Young Hyeh Ko; Jun Ho Ji; Won Seog Kim; Seok Jin Kim
Journal:  Korean J Intern Med       Date:  2016-02-22       Impact factor: 2.884

3.  Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.

Authors:  Murali Kesavan; Jan Boucek; William MacDonald; Andrew McQuillan; J Harvey Turner
Journal:  Diagnostics (Basel)       Date:  2017-05-12

4.  [Prognostic study of 229 follicular lymphoma patients treated with rituximab combined with chemotherapy].

Authors:  N Wang; P P Xu; L Wang; S Cheng; W L Zhao; H P Sun
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.